Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes

World Journal of Gastroenterology

Volumn 10, Issue 15, 2004, Pages 2259-2262

  Zou, Sheng Quan ^a   Qu, Zhen Liang ^b   Li, Zhan Fei ^a   Wang, Xin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Chinese PLA 254 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PLASMID VECTOR; TELOMERASE REVERSE TRANSCRIPTASE; VIRUS PROTEIN;

ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; EUKARYOTE; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 4344657686     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i15.2259     Document Type: Article

References (31)

1. Aragoan M, Maisano R, Panetta S, Giudice A., Morelli M, La Torre I, La Torre F. Telomere lenght maintenance in aging and carcinogenesis. Int J Oncol 2000; 17: 981-989
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
3. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch 2000; 437: 1-16
4. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001; 269: 1-12
5. Horikawa I, Barrett JC. Cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst 2001; 93: 1171-1173
6. Zhou WP, Shen QH, Gu BY, Ren H, Zhang DH. Effects of hepatitis B virus X gene on apoptosis and the activity of telomerase in HepG2 cells. Zhonghua Ganzhangbing Zazhi 2000; 8: 212-214
7. Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998; 4: 392-396
8. Wang W, Gu G, Hu M. Expression and significance of hepatitis B virus genes in human primary intrahepatic cholangiocarcinoma and its surrounding tissue. Zhonghua Zhongliu Zazhi 1996; 18: 127-130
9. Qu ZL, Zou SQ, Zhen SL, Wu XZ, Cui NQ. The expression and significance of hepatitis B virus X protein in extrahepatic bile duct carcinomas and the surrounding noncancerous tissues. Zhonghua Shiyan Waike Zazhi 2002; 19: 401-402
10. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Inhibition of T cell activation by normal human biliary epithelial cells. J Hepathol 1999; 31: 1026-1033
11. Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998; 273: 33347-33353
12. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001; 120: 190-199
13. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-959
14. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 2000; 6: 1239-1247
15. Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selinova G, Peterson C, Wiman KG, Pisa P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000; 19: 5123-5133
16. Oh S, Song YH, Yim J, Kim TK. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 2000; 19: 1485-1490
17. Gunes C, Lichtsteiner S, Vasserot AP, Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 2000; 60: 2116-2121
18. Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acid Res 2000; 28: 2557-2562
19. Baege AC, Berger A, Schlegel R. Cervical ephitelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am J Pathol 2002; 160: 1251-1257
20. Gozuacik D, Murakami Y, Saigo K, Chami M, Mugnier C, Lagorce D, Okanoue T, Urashima T, Brechot C, Paterlini-Brechot P. Identification of human cancer-related genes by naturally occuring hepatitis B virus DNA tagging. Oncogene 2001; 20: 6233-6240
21. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastoenterol 2001; 36: 651-660
22. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003; 24: 1167-1176
23. Qu ZL, Zhou SQ, Wei GH, Sun ZC, Wu XZ. In situ nucleic acid detection f HBV X gene in extrahepatic biliary tract carcinomas and its clinicopathological significance. Zhonghua Waike Zazhi 2004; 42: 88-91
24. Liu X, Zhou S, Qiu F. Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus. Zhonghua Waike Zazhi 2002; 40: 420-422
25. Diao J, Garces R, Richardson CD. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infection and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001; 12: 189-205
26. Guo SP, Wang WL, Zhai YQ, Zhao YL. Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World J Gastroenterol 2001; 7: 340-344
27. Wang WL. Expression of five different antigens of HBV in human intrahepatic cholangiocarcinoma and cholangiohepatocarcinoma. Zhonghua Zhongliu Zazhi 1993; 15: 252-255
28. Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001; 75: 215-225
29. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742-745
30. Kwon JA, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Biol Chem 2003; 384: 203-212
31. Choi M, Lee H, Rho HM. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter. IUBMB Life 2002; 53: 309-317